Status:
COMPLETED
Six Months DHEA Treatment in Female Adrenal Failure
Lead Sponsor:
University of Aarhus
Conditions:
Adrenal Insufficiency
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
DHEA is an adrenal deriven androgen precourser. The impact of DHEA substitution therapy in adrenal failure is unknown as well as the physiologically effects of DHEA is unknown. Effects of physiologica...
Eligibility Criteria
Inclusion
- Female,
- Adrenal insuficiency,
- Stable and safe anticonception,
- Stable hydrocortison substituation treatment.
Exclusion
- Neoplastic and thromboembolic disease,
- Diabetes mellitus.
Key Trial Info
Start Date :
October 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2003
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00471900
Start Date
October 1 2001
End Date
February 1 2003
Last Update
May 10 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.